moxifloxacin has been researched along with Pus in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Egorov, VI; Kozarenko, AV | 1 |
Chuchueva, NG; Ivanchenko, OA; Lopatin, AS | 1 |
Barzilai, A; Diamantstein, L; Gruzman, G; Keller, N; Rubinovitch, B; Rubinstein, E; Yoseph, G | 1 |
3 other study(ies) available for moxifloxacin and Pus
Article | Year |
---|---|
[Effectiveness of a new fluoroquinolone antibiotic avelox in the treatment of suppurative sinusitis].
Topics: Acute Disease; Adolescent; Adult; Anti-Infective Agents; Aza Compounds; Female; Fluoroquinolones; Frontal Sinusitis; Humans; Male; Maxillary Sinusitis; Middle Aged; Moxifloxacin; Quinolines; Sinusitis; Suppuration; Time Factors | 2002 |
[Avelox efficacy in the treatment of acute purulent rhinosinusitis].
Topics: Acute Disease; Anti-Infective Agents; Antitubercular Agents; Aza Compounds; Female; Fluoroquinolones; Follow-Up Studies; Humans; Male; Maxillary Sinusitis; Moxifloxacin; Quinolines; Rhinitis; Suppuration; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
The effect of albumin, globulin, pus and dead bacteria in aerobic and anaerobic conditions on the antibacterial activity of moxifloxacin, trovafloxacin and ciprofloxacin against Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli.
Topics: Albumins; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Globulins; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Pneumococcal Infections; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Suppuration | 2000 |